Title
|
Company Name
|
Platform /
Modality
|
Target
|
Investor/Partner
Relations
|
| A Novel Polymer Trileaflet Heart Valve |
Innovia LLC |
Point of Care |
|
VC, Licensing, Strategic Partner |
| Gold Nanoparticle X-ray Contrast Agent |
Nanoprobes, Incorporated |
Imaging |
|
Strategic Partner |
| Heart Failure Diagnostic and Clinical Trial Enrollment Tool |
Gwathmey, Inc. |
Small Molecules |
Selection of responders and non-responders for clinical trials |
VC, Licensing, Strategic Partner |
| Hypertension ELISA |
Detroit R&D, Inc. |
Biologic |
Arachidonic acid metabolites (metabolites of epoxide hydrolase and P450)-dependent hypertension is targeted. |
Licensing, Strategic Partner |
| Implantable Left Ventricular Assist Pump for Heart Failure Patients |
MiTiHeart Corporation |
Other |
|
VC, Licensing, Strategic Partner |
| Infection Resistant Catheter |
Whalen Biomedical Inc. |
Other |
|
VC, Strategic Partner, Other |
| Long-acting Native GLP-1 Frmulation for the Treatment of Diabetes |
PharmaIN, Ltd. |
Biologic |
GLP-1 receptor (glucagon-like peptide 1 receptor) |
VC, Licensing, Strategic Partner |
| Molecular Imaging of VEGF and EGF Receptors |
SibTech, Inc. |
Imaging |
VEGF and EGF receptors |
VC, Licensing, Strategic Partner |
| Real Tiime Risk of Mortality and Instability : Bioinformatics for the PICU |
Realtromins Inc |
Other (ICU Monitoring Device) |
|
VC, Licensing, Manufacturing, Strategic Partner, Other |
| SERF Ablation [TM] for Cancer Therapy and Cardiac Arrhythmias |
Thermedical |
Point of Care |
|
VC |
| Ultra Low Profile Angioplasty Balloon Catheter |
Zylon Corporation |
Point of Care |
|
VC, Licensing, Manufacturing, Strategic Partner |
| Wound closure device |
Surgical Eneregetics Inc. |
Other (Wound closure) |
Reconstructive and Orthopedic Surgery |
VC, Licensing |
represents column sort